BioNTech reports FY 2025 revenue of €2.87B and IFRS net loss of €1.14B
Compartilhar
BioNTech (NASDAQ:BNTX), the biotechnology firm that rose to global prominence with its COVID-19 vaccine, reported full-year 2025 revenues of €2.87 billion on Tuesday.
